Loading provider…
Loading provider…
Cardiovascular Disease Physician in San Diego, CA
NPI: 1124043948Primary Employer
Regents of the University of California
health.ucsd.edu
HQ Phone
Get M.D. Anthony's Phone NumberMobile
Get M.D. Anthony's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1971 - 2027
NJ State Medical License
1969

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Cardiovascular Disease
University of California Davis Health
Fellowship • Cardiovascular Disease
1971 - 1973
USPHS Hospital
Residency • Internal Medicine
1969 - 1971
St Vincent Hospital
Internship • Transitional Year
1968 - 1969
Rutgers New Jersey Medical School
njms.rutgers.edu
Medical School
Until 1968
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 351 | 356 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 103 | 154 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 75 | 108 |
| 4 | 763763D radiographic procedure | 55 | 55 |
| 5 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 49 | 60 |
Authors: Smith, M D, Kwan, O L, DeMaria, A N
Journal: JAMA
Authors: Li, James, Reaven, Nancy L, Funk, Susan E, Lovett, Joseph E, DeMaria, Anthony N
Journal: Am J Cardiol
Publication Date: 2008-11-12
Authors: Rovai, D, Lubrano, V, Vassalle, C, Paterni, M, Marini, C, Kozakova, M, Castellari, M, Taddei, L, Trivella, M G, Distante, A, DeMaria, A N, L'Abbate, A
Journal: J Am Soc Echocardiogr
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: TQJ230
Lead Sponsor: CardioVascular BioTherapeutics, Inc.
Intervention / Treatment: COMBINATION_PRODUCT: Placebo, COMBINATION_PRODUCT: Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141) - low dose, COMBINATION_PRODUCT: Human Recombinant Fibroblast Growth Factor-1 (FGF1-141) - high dose
Lead Sponsor: Longeveron Inc.
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Longeveron Mesenchymal Stem Cells (LMSCs)